Transfusion-related Acute Lung Injury during Liver Transplantation: A Scoping Review

Abstract Background Liver transplantation is associated with significant blood loss, often requiring massive blood product transfusion. Transfusion-related acute lung injury (TRALI) is a devastating cause of transfusion-related deaths. While reports have investigated the general incidence of TRALI, the incidence of TRALI specifically following transfusion during liver transplant remains unclear. This scoping review summarizes existing literature regarding TRALI during the liver transplantation perioperative period. Methods Databases were searched for all articles and abstracts reporting on TRALI after liver transplantation. Data collected included: number of patients studied; patient characteristics; incidences of TRALI; TRALI characteristics; and patient outcomes. The primary outcome investigated was the incidence of TRALI in the setting of liver transplantation. Results 13 full-text citations were included in this review. The incidence of TRALI post-liver transplant was 0.68% (65/9554). Based on reported transfusion data, patients diagnosed with TRALI received an average of 10.92 ± 10.81 units of pRBC, 20.05 ± 15.72 units of FFP, and 5.75 ± 10.00 units of platelets. Common interventions following TRALI diagnosis included mechanical ventilation with positive end-expiratory pressure (PEEP), inhaled high-flow oxygen, inhaled pulmonary vasodilator, and pharmacological treatment using pressors or inotropes, corticosteroids, or diuretics. Based on reported mortality data, 26.67% of patients (12 out of 45) diagnosed with TRALI died during the postoperative period. Conclusions This scoping review underscores the importance of better understanding the incidence and presentation of TRALI after liver transplant surgery. The clinical implications of these results warrant the development of identification and management strategies for liver transplant patients at increased risk for developing TRALI.